Yihao Yang

Mr. Yihao Yang


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2026 in Agriculture
Verified
Journal Article
Open access
PDF file
QZqingzhen zhu
qingzhen zhu
YYYihao Yang
Yihao Yang
BSBaoyi Sun
Baoyi Sun
YZYujie Zhou
Yujie Zhou
LZLiyuan Zhang
Liyuan Zhang
朱Z朱艳秋 Zhu
朱艳秋 Zhu
Ultraviolet radiation is increasingly used as a controllable physical technology for crop disease management, but inconsistencies in parameter reporting, the validation scale, and engineering evidence hinder cross-study comparisons and practical translation. Following the PRISMA 2020 statement, this systematic review searched the Web of Science Core Collection and IEEE Xplore, screened eligible studies, and conducted full-text data extraction and structured coding. A total of 80 studies were evaluated across four domains: UV treatment parameter reporting, highest validation level, translational maturity, and engineering characteristics of application equipment. The treatment frequency or number of applications and wavelength were explicitly reported in 83.8% and 76.3% of studies, respectively, whereas irradiance and post-treatment light or dark conditions were reported in only 36.3% and 35.0%. In 57.5% of studies, the highest validation level remained limited to in vitro pathogen assays, detached-material experiments, or controlled-environment whole-plant experiments; low and low-medium translational maturity together accounted for 62.5%. Among the 11 equipment-related studies included in this review, the operating speed and target-surface dose calibration were reported more frequently than within-canopy dose uniformity, shading effects, and operational control. UV-based crop disease control is progressing toward field and equipment applications, but incomplete parameter reporting, discontinuities in the production-scale evidence chain, and unstable dose delivery still constrain reproducibility and scale-up. Future research should establish minimum reporting standards, strengthen multi-site and multi-season validation, translate biologically effective doses into equipment operating parameters, and develop closed-loop control based on actual target-surface dose monitoring.